Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells

Documenti analoghi

• High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
  di: Emi Sometani, et al.
  Pubblicazione: (2024)
• What we know and need to know about Fontan‐associated liver disease
  di: Kunimaro Furuta
  Pubblicazione: (2024)
• The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs
  di: Kazuhiro Murai, et al.
  Pubblicazione: (2025)
• Optimal Stenting Strategy During Chemotherapy: Impact of Time to First Reintervention on Survival in Malignant Hilar Biliary Obstruction
  di: Katsuhiko Sato, et al.
  Pubblicazione: (2026)
• Featured Cover
  di: Shusuke Kumazaki, et al.
  Pubblicazione: (2024)